EMMPRIN, an upstream regulator of MMPs, in CNS biology

Matrix Biology

Volumn 44-46, Issue , 2015, Pages 138-146

  Kaushik, Deepak Kumar ^a   Hahn, Jennifer Nancy ^a   Yong, V Wee ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

CD147; Extracellular matrix; Inflammation; MMP inducer; Multiple sclerosis

Indexed keywords

CD147 ANTIGEN; MATRIX METALLOPROTEINASE; BSG PROTEIN, HUMAN; CELL ADHESION MOLECULE; MONOCARBOXYLATE TRANSPORTER;

ALZHEIMER DISEASE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; ENZYME INDUCTION; GLIOMA; HOMEOSTASIS; HUMAN; KNOCKOUT MOUSE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INJURY; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY;

ANTIGENS, CD147; CELL ADHESION MOLECULES; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMEOSTASIS; HUMANS; MATRIX METALLOPROTEINASES; MOLECULAR TARGETED THERAPY; MONOCARBOXYLIC ACID TRANSPORTERS;

EID: 84930755176     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2015.01.018     Document Type: Review

References (87)

1. Lau L.W., Cua R., Keough M.B., Haylock-Jacobs S., Yong V.W. Pathophysiology of the brain extracellular matrix: a new target for remyelination. Nat Rev 2013, 14:722-729.
2. Rauch U. Extracellular matrix components associated with remodeling processes in brain. Cell Mol Life Sci 2004, 61:2031-2045.
3. Yong V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev 2005, 6:931-944.
4. Gu Z., Kaul M., Yan B., Kridel S.J., Cui J., Strongin A., et al. S-Nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 2002, 297:1186-1190.
5. Yong V.W., Power C., Forsyth P., Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat Rev 2001, 2:502-511.
6. Mroczko B., Groblewska M., Barcikowska M. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study. J Alzheimers Dis 2013, 37:273-283.
7. Chaturvedi M., Kaczmarek L. Mmp-9 inhibition: a therapeutic strategy in ischemic stroke. Mol Neurobiol 2014, 49:563-573.
8. Biswas C. Tumor cell stimulation of collagenase production by fibroblasts. Biochem Biophys Res Commun 1982, 109:1026-1034.
9. Biswas C., Zhang Y., DeCastro R., Guo H., Nakamura T., Kataoka H., et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995, 55:434-439.
10. Fossum S., Mallett S., Barclay A.N. The MRC OX-47 antigen is a member of the immunoglobulin superfamily with an unusual transmembrane sequence. Eur J Immunol 1991, 21:671-679.
11. Miyauchi T., Masuzawa Y., Muramatsu T. The basigin group of the immunoglobulin superfamily: complete conservation of a segment in and around transmembrane domains of human and mouse basigin and chicken HT7 antigen. J Biochem 1991, 110:770-774.
12. Yu X.L., Hu T., Du J.M., Ding J.P., Yang X.M., Zhang J., et al. Crystal structure of HAb18G/CD147: implications for immunoglobulin superfamily homophilic adhesion. J Biol Chem 2008, 283:18056-18065.
13. Vaughn D.E., Bjorkman P.J. The (Greek) key to structures of neural adhesion molecules. Neuron 1996, 16:261-273.
14. Redzic J.S., Armstrong G.S., Isern N.G., Jones D.N., Kieft J.S., Eisenmesser E.Z. The retinal specific CD147 Ig0 domain: from molecular structure to biological activity. J Mol Biol 2011, 411:68-82.
15. Harpaz Y., Chothia C. Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains. J Mol Biol 1994, 238:528-539.
16. Biswas C. Collagenase stimulation in cocultures of human fibroblasts and human tumor cells. Cancer Lett 1984, 24:201-207.
17. Nabeshima K., Lane W.S., Biswas C. Partial sequencing and characterization of the tumor cell-derived collagenase stimulatory factor. Arch Biochem Biophys 1991, 285:90-96.
18. Guo H., Majmudar G., Jensen T.C., Biswas C., Toole B.P., Gordon M.K. Characterization of the gene for human EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases. Gene 1998, 220:99-108.
19. Sun J., Hemler M.E. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res 2001, 61:2276-2281.
20. Berditchevski F., Chang S., Bodorova J., Hemler M.E. Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha3beta1 complexes with EMMPRIN/basigin/OX47/M6. J Biol Chem 1997, 272:29174-29180.
21. Curtin K.D., Meinertzhagen I.A., Wyman R.J. Basigin (EMMPRIN/CD147) interacts with integrin to affect cellular architecture. J Cell Sci 2005, 118:2649-2660.
22. Tang W., Hemler M.E. Caveolin-1 regulates matrix metalloproteinases-1 induction and CD147/EMMPRIN cell surface clustering. J Biol Chem 2004, 279:11112-11118.
23. Yurchenko V., O'Connor M., Dai W.W., Guo H., Toole B., Sherry B., et al. CD147 is a signaling receptor for cyclophilin B. Biochem Biophys Res Commun 2001, 288:786-788.
24. Yurchenko V., Zybarth G., O'Connor M., Dai W.W., Franchin G., Hao T., et al. Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J Biol Chem 2002, 277:22959-22965.
25. Boulos S., Meloni B.P., Arthur P.G., Majda B., Bojarski C., Knuckey N.W. Evidence that intracellular cyclophilin A and cyclophilin A/CD147 receptor-mediated ERK1/2 signalling can protect neurons against in vitro oxidative and ischemic injury. Neurobiol Dis 2007, 25:54-64.
26. Damsker J.M., Bukrinsky M.I., Constant S.L. Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A. J Leukoc Biol 2007, 82:613-618.
27. Pushkarsky T., Yurchenko V., Vanpouille C., Brichacek B., Vaisman I., Hatakeyama S., et al. Cell surface expression of CD147/EMMPRIN is regulated by cyclophilin 60. J Biol Chem 2005, 280:27866-27871.
28. Kirk P., Wilson M.C., Heddle C., Brown M.H., Barclay A.N., Halestrap A.P. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J 2000, 19:3896-3904.
29. Schlosshauer B., Herzog K.H. Neurothelin: an inducible cell surface glycoprotein of blood-brain barrier-specific endothelial cells and distinct neurons. J Cell Biol 1990, 110:1261-1274.
30. Fan Q.W., Yuasa S., Kuno N., Senda T., Kobayashi M., Muramatsu T., et al. Expression of basigin, a member of the immunoglobulin superfamily, in the mouse central nervous system. Neurosci Res 1998, 30:53-63.
31. Vetrivel K.S., Zhang X., Meckler X., Cheng H., Lee S., Gong P., et al. Evidence that CD147 modulation of beta-amyloid (Abeta) levels is mediated by extracellular degradation of secreted Abeta. J Biol Chem 2008, 283:19489-19498.
32. Risau W., Hallmann R., Albrecht U., Henke-Fahle S. Brain induces the expression of an early cell surface marker for blood-brain barrier-specific endothelium. EMBO J 1986, 5:3179-3183.
33. Fadool J.M., Linser P.J. 5A11 antigen is a cell recognition molecule which is involved in neuronal-glial interactions in avian neural retina. Dev Dyn 1993, 196:252-262.
34. Sameshima T., Nabeshima K., Toole B.P., Yokogami K., Okada Y., Goya T., et al. Expression of EMMPRIN (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int J Cancer 2000, 88:21-27.
35. Igakura T., Kadomatsu K., Kaname T., Muramatsu H., Fan Q.W., Miyauchi T., et al. A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis. Dev Biol 1998, 194:152-165.
36. Kuno N., Kadomatsu K., Fan Q.W., Hagihara M., Senda T., Mizutani S., et al. Female sterility in mice lacking the basigin gene, which encodes a transmembrane glycoprotein belonging to the immunoglobulin superfamily. FEBS Lett 1998, 425:191-194.
37. Naruhashi K., Kadomatsu K., Igakura T., Fan Q.W., Kuno N., Muramatsu H., et al. Abnormalities of sensory and memory functions in mice lacking Bsg gene. Biochem Biophys Res Commun 1997, 236:733-737.
38. Igakura T., Kadomatsu K., Taguchi O., Muramatsu H., Kaname T., Miyauchi T., et al. Roles of basigin, a member of the immunoglobulin superfamily, in behavior as to an irritating odor, lymphocyte response, and blood-brain barrier. Biochem Biophys Res Commun 1996, 224:33-36.
39. Ochrietor J.D., Linser P.J. 5A11/Basigin gene products are necessary for proper maturation and function of the retina. Dev Neurosci 2004, 26:380-387.
40. Hori K., Katayama N., Kachi S., Kondo M., Kadomatsu K., Usukura J., et al. Retinal dysfunction in basigin deficiency. Invest Ophthalmol Vis Sci 2000, 41:3128-3133.
41. Besse F., Mertel S., Kittel R.J., Wichmann C., Rasse T.M., Sigrist S.J., et al. The Ig cell adhesion molecule Basigin controls compartmentalization and vesicle release at Drosophila melanogaster synapses. J Cell Biol 2007, 177:843-855.
42. Weiner H.L. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J Neurol 2008, 255(Suppl. 1):3-11.
43. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747.
44. Rice G.P., Hartung H.P., Calabresi P.A. Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. Neurology 2005, 64:1336-1342.
45. Agrawal S.M., Silva C., Wang J., Tong J.P., Yong V.W. A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis. J Neuroinflammation 2012, 9:64.
46. Agrawal S.M., Williamson J., Sharma R., Kebir H., Patel K., Prat A., et al. Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis. Brain 2013, 136:1760-1777.
47. Agrawal S.M., Silva C., Tourtellotte W.W., Yong V.W. EMMPRIN: a novel regulator of leukocyte transmigration into the CNS in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci 2011, 31:669-677.
48. Bar-Or A., Nuttall R.K., Duddy M., Alter A., Kim H.J., Ifergan I., et al. Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 2003, 126:2738-2749.
49. Minagar A., Alexander J.S. Blood-brain barrier disruption in multiple sclerosis. Mult Scler 2003, 9:540-549.
50. Cossins J.A., Clements J.M., Ford J., Miller K.M., Pigott R., Vos W., et al. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol 1997, 94:590-598.
51. Kouwenhoven M., Ozenci V., Gomes A., Yarilin D., Giedraitis V., Press R., et al. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes. J Autoimmun 2001, 16:463-470.
52. Lindberg R.L., De Groot C.J., Montagne L., Freitag P., van der Valk P., Kappos L., et al. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 2001, 124:1743-1753.
53. Pagenstecher A., Stalder A.K., Kincaid C.L., Shapiro S.D., Campbell I.L. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 1998, 152:729-741.
54. Planas A.M., Sole S., Justicia C. Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol Dis 2001, 8:834-846.
55. Rosenberg G.A., Navratil M., Barone F., Feuerstein G. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 1996, 16:360-366.
56. Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., Barone F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998, 29:1020-1030.
57. Clark A.W., Krekoski C.A., Bou S.S., Chapman K.R., Edwards D.R. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett 1997, 238:53-56.
58. Fujimura M., Gasche Y., Morita-Fujimura Y., Massengale J., Kawase M., Chan P.H. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 1999, 842:92-100.
59. Montaner J., Alvarez-Sabin J., Molina C., Angles A., Abilleira S., Arenillas J., et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 2001, 32:1759-1766.
60. Burggraf D., Liebetrau M., Martens H.K., Wunderlich N., Jager G., Dichgans M., et al. Matrix metalloproteinase induction by EMMPRIN in experimental focal cerebral ischemia. Eur J Neurosci 2005, 22:273-277.
61. Zhu W., Khachi S., Hao Q., Shen F., Young W.L., Yang G.Y., et al. Upregulation of EMMPRIN after permanent focal cerebral ischemia. Neurochem Int 2008, 52:1086-1091.
62. Tran H.T., LaFerla F.M., Holtzman D.M., Brody D.L. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-beta accumulation and independently accelerates the development of tau abnormalities. J Neurosci 2011, 31:9513-9525.
63. Meyer-Luehmann M., Spires-Jones T.L., Prada C., Garcia-Alloza M., de Calignon A., Rozkalne A., et al. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 2008, 451:720-724.
64. Li M., Shang D.S., Zhao W.D., Tian L., Li B., Fang W.G., et al. Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier. J Immunol 2009, 182:5778-5788.
65. Liao M.C., Van Nostrand W.E. Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro. Biochemistry 2010, 49:1127-1136.
66. Mroczko B., Groblewska M., Zboch M., Kulczynska A., Koper O.M., Szmitkowski M., et al. Concentrations of matrix metalloproteinases and their tissue inhibitors in the cerebrospinal fluid of patients with Alzheimer's disease. J Alzheimers Dis 2014, 40:351-357.
67. Langenfurth A., Rinnenthal J.L., Vinnakota K., Prinz V., Carlo A.S., Stadelmann C., et al. Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases. J Neurosci Res 2014, 92:275-286.
68. Zhou S., Zhou H., Walian P.J., Jap B.K. CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta-peptide production. Proc Natl Acad Sci U S A 2005, 102:7499-7504.
69. Nahalkova J., Volkmann I., Aoki M., Winblad B., Bogdanovic N., Tjernberg L.O., et al. CD147, a gamma-secretase associated protein is upregulated in Alzheimer's disease brain and its cellular trafficking is affected by presenilin-2. Neurochem Int 2010, 56:67-76.
70. Ridnour L.A., Dhanapal S., Hoos M., Wilson J., Lee J., Cheng R.Y., et al. Nitric oxide-mediated regulation of beta-amyloid clearance via alterations of MMP-9/TIMP-1. J Neurochem 2012, 123:736-749.
71. Tian L., Zhang Y., Chen Y., Cai M., Dong H., Xiong L. EMMPRIN is an independent negative prognostic factor for patients with astrocytic glioma. PLoS One 2013, 8:e58069.
72. Tsai W.C., Chen Y., Huang L.C., Lee H.S., Ma H.I., Huang S.M., et al. EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas. J Neurooncol 2013, 114:281-290.
73. Sawaya R.E., Yamamoto M., Gokaslan Z.L., Wang S.W., Mohanam S., Fuller G.N., et al. Expression and localization of 72kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 1996, 14:35-42.
74. Lampert K., Machein U., Machein M.R., Conca W., Peter H.H., Volk B. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Am J Pathol 1998, 153:429-437.
75. Nakada M., Nakamura H., Ikeda E., Fujimoto N., Yamashita J., Sato H., et al. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am J Pathol 1999, 154:417-428.
76. Gu J., Zhang C., Chen R., Pan J., Wang Y., Ming M., et al. Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas. Eur J Pediatr 2009, 168:705-710.
77. Sameshima T., Nabeshima K., Toole B.P., Yokogami K., Okada Y., Goya T., et al. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett 2000, 157:177-184.
78. Egawa N., Koshikawa N., Tomari T., Nabeshima K., Isobe T., Seiki M. Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells. J Biol Chem 2006, 281:37576-37585.
79. Grass G.D., Bratoeva M., Toole B.P. Regulation of invadopodia formation and activity by CD147. J Cell Sci 2012, 125:777-788.
80. Liang Q., Xiong H., Gao G., Xiong K., Wang X., Zhao Z., et al. Inhibition of basigin expression in glioblastoma cell line via antisense RNA reduces tumor cell invasion and angiogenesis. Cancer Biol Ther 2005, 4:759-762.
81. Xu J., Shen Z.Y., Chen X.G., Zhang Q., Bian H.J., Zhu P., et al. A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation. Hepatology 2007, 45:269-276.
82. Wyss M.T., Jolivet R., Buck A., Magistretti P.J., Weber B. In vivo evidence for lactate as a neuronal energy source. J Neurosci 2011, 31:7477-7485.
83. Bouzier-Sore A.K., Voisin P., Canioni P., Magistretti P.J., Pellerin L. Lactate is a preferential oxidative energy substrate over glucose for neurons in culture. J Cereb Blood Flow Metab 2003, 23:1298-1306.
84. Maekawa F., Minehira K., Kadomatsu K., Pellerin L. Basal and stimulated lactate fluxes in primary cultures of astrocytes are differentially controlled by distinct proteins. J Neurochem 2008, 107:789-798.
85. Suzuki A., Stern S.A., Bozdagi O., Huntley G.W., Walker R.H., Magistretti P.J., et al. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 2011, 144:810-823.
86. Philp N.J., Ochrietor J.D., Rudoy C., Muramatsu T., Linser P.J. Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse. Invest Ophthalmol Vis Sci 2003, 44:1305-1311.
87. Fan Q.W., Kadomatsu K., Uchimura K., Muramatsu T. Embigin/basigin subgroup of the immunoglobulin superfamily: different modes of expression during mouse embryogenesis and correlated expression with carbohydrate antigenic markers. Dev Growth Differ 1998, 40:277-286.